Iron Blocks the Accumulation and Activity of Tetracyclines in Bacteria

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 5, 2004, Pages 1892-1894

  Avery, Angela M ^a   Goddard, Helen J ^a   Sumner, Edward R ^a   Avery, Simon V ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOACYL TRANSFER RNA; CALCIUM SULFATE; FERRITIN; FERROUS SULFATE; FERROZINE; IRON; MAGNESIUM SULFATE; MANGANESE SULFATE; MINOCYCLINE; OXYTETRACYCLINE; SUPEROXIDE DISMUTASE; TETRACYCLINE; TETRACYCLINE DERIVATIVE; TRANSFERRIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIOSTASIS; CONTROLLED STUDY; CULTURE MEDIUM; DRUG ACCUMULATION; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIA; CULTURE MEDIA; ESCHERICHIA COLI; IRON; OXYTETRACYCLINE; STAPHYLOCOCCUS AUREUS; SUPEROXIDE DISMUTASE; TETRACYCLINES;

EID: 2142822839     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.5.1892-1894.2004     Document Type: Article

References (23)

1. Andrews, W. H., and L. A. Magee. 1973. Divalent cation reversal of tetracycline-inhibited respiration of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 3:645-646.
2. Angrave, F. E., and S. V. Avery. 2001. Antioxidant functions required for insusceptibility of Saccharomyces cerevisiae to tetracycline antibiotics. Antimicrob. Agents Chemother. 45:2939-2942.
3. Avery, S. V., S. Malkapuram, C. Mateus, and K. S. Babb. 2000. Cu/Zn superoxide dismutase is required for oxytetracycline resistance of Saccharomyces cerevisiae. J. Bacteriol. 182:76-80.
4. Bechet, M., and R. Blondeau. 1998. Iron deficiency-induced tetracycline production in submerged cultures by Streptomyces aureofaciens. J. Appl. Microbiol. 84:889-894.
5. Blackburn, A. S., and S. V. Avery. 2003. Genome-wide screening of Saccharomyces cerevisiae to identify genes required for antibiotic insusceptibility of eukaryotes. Antimicrob. Agents Chemother. 47:676-681.
6. Braun, V. 2001. Iron uptake mechanisms and their regulation in pathogenic bacteria. Int. J. Med. Microbiol. 291:67-79.
7. Carlioz, A., and D. Touati. 1986. Isolation of superoxide dismutase mutants in Escherichia coli - is superoxide dismutase necessary for aerobic life? EMBO J. 5:623-630.
8. Chopra, I., and M. Roberts. 2001. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol. Mol. Biol. Rev. 65:232-260.
9. Druckbeimer, W. 1975. Tetracyclines: chemistry, biochemistry and structure-activity relations. Angew. Chem. 14:721-774.
10. Dubrac, S., and D. Touati. 2002. Fur-mediated transcriptional and post-transcriptional regulation of FeSOD expression in Escherichia coli. Microbiology 148:147-156.
11. Grenier, D., M.-P. Huot, and D. Mayrand. 2000. Iron-chelating activity of tetracyclines and its impact on the susceptibility of Actinobacillus actinomy-cetemcomitans to these antibiotics. Antimicrob. Agents Chemother. 44:763-766.
12. Jelikic-Stankov, M., D. Veselinovic, D. Malesev, and Z. Radovic. 1989. Spectrophotometric determination of oxytetracycline in pharmaceutical preparations using sodium molybdate as analytical reagent. J. Pharm. Biomed. Anal. 7:1565-1570.
13. Jochsberger, J., Cutie, A., and J. Mills. 1979. Differential pulse polarography of tetracycline: determination of complexing tendencies of tetracycline analogs in the presence of cations. J. Pharm. Sci. 68:1061-1063.
14. Martin, R. B. 1985. Tetracyclines and daunorubicin. Metal Ions Biol. Syst. 19:19-52.
15. Miles, A. A., and J. P. Maskell. 1985. The antagonism of tetracycline and ferric iron in vivo. J. Med. Microbiol. 20:17-26.
16. Nanavaty, J., J. E. Mortensen, and T. R. Shryock. 1998. The effects of environmental conditions on the in vitro activity of selected antimicrobial agents against Escherichia coli. Curr. Microbiol. 36:212-215.
17. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed.. Approved standard Mt-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa.
18. Nikaido, H., and D. G. Thanassi. 1993. Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples. Antimicrob. Agents Chemother. 37:1393-1399.
19. Pradines, B., C. Rogier, T. Fusai, J. Mosnier, W. Daries, E. Barret, and D. Parzy. 2001. In vitro activities of antibiotics against Plasmodium falciparum are inhibited by iron. Antimicrob. Agents Chemother. 45:1746-1750.
20. Schnappinger, D., and W. Hillen. 1996. Tetracyclines: antibiotic action, uptake, and resistance mechanisms. Arch. Microbiol. 165:359-369.
21. Thanassi, D. G., G. S. B. Huh, and H. Nikaido. 1995. Role of outer membrane barrier in efflux-mediated tetracycline resistance of Escherichia coli. J. Bacteriol. 177:998-1007.
22. Touati, D., M. Jacques, B. Tardat, L. Bouchard, and S. Despied. 1995. Lethal oxidative damage and mutagenesis are generated by iron in Δfur mutants of Escherichia coli: protective role of superoxide dismutase. J. Bacteriol. 177:2305-2314.
23. Yamaguchi, A., H. Ohmori, M. Kaneko-Ohdera, T. Nomura, and T. Sawai. 1991. ΔpH-dependent accumulation of tetracycline in Escherichia coli. Antimicrob. Agents Chemother. 35:53-56.